South Africa Crispr And Cas Genes Market Size & Outlook
South Africa crispr and cas genes market, 2018-2030 (US$M)
Related Markets
South Africa crispr and cas genes market highlights
- The South Africa crispr and cas genes market generated a revenue of USD 30.4 million in 2024 and is expected to reach USD 61.2 million by 2030.
- The South Africa market is expected to grow at a CAGR of 12.7% from 2025 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2024.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
Crispr and cas genes market data book summary
| Market revenue in 2024 | USD 30.4 million |
| Market revenue in 2030 | USD 61.2 million |
| Growth rate | 12.7% (CAGR from 2025 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.6% of the global crispr and cas genes market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia crispr and cas genes market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 63.1 million by 2030.
Product was the largest segment with a revenue share of 84.54% in 2024. Horizon Databook has segmented the South Africa crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of a significant target population in South Africa is anticipated to drive its CRISPR technology market over the forecast period. Moreover, a growing disease burden is expected to greatly influence the country’s market growth by enhancing the application of gene editing technologies.
In March 2020, the KRISP, along with Thermos Fisher Scientific, opened a CRISPR-Cas9 laboratory in South Africa. This laboratory is expected to provide advanced training on genetic and epigenetic editing techniques and is available for scientific services, which can boost the penetration of CRISPR technologies in this region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR And Cas Genes Market Scope
CRISPR And Cas Genes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa crispr and cas genes market size, by product & service, 2018-2030 (US$M)
South Africa CRISPR And Cas Genes Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
